How does Adamax compare to Semax and NA-Semax-Amidate?

All three share the ACTH 4-10 core sequence. Semax is the base compound. NA-Semax-Amidate adds acetylation and amidation for improved stability. Adamax replaces the amide with an adamantane group — a bulky, lipophilic cage structure that may further enhance BBB penetration and receptor binding duration. Adamax is the most structurally modified but also has the least published evidence.

Is there clinical evidence for Adamax?

No. Adamax has zero PubMed-indexed publications. Its proposed benefits are extrapolated from Semax research (which has moderate clinical evidence) plus the known pharmacological effects of adamantane modifications (used in other drugs like amantadine and memantine). This is an important limitation — enhanced BBB penetration is theoretically sound but unvalidated for this specific compound.

Adamax

An enhanced derivative of Semax with N-terminal acetylation and C-terminal adamantane modification, engineered for superior blood-brain barrier penetration, BDNF upregulation, and sustained nootropic effects.

LimitedLimited Data

What is Adamax?

Adamax is a synthetic nootropic peptide and enhanced derivative of Semax, modified with N-terminal acetylation and a C-terminal adamantane group. These structural modifications improve stability against enzymatic degradation and enhance blood-brain barrier penetration compared to the parent compound. Like Semax, Adamax is derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), but its modifications are designed to produce more potent and sustained nootropic effects. It is primarily researched for cognitive enhancement, neuroprotection, and neuroplasticity via BDNF and TrkB receptor modulation. Adamax has no PubMed-indexed publications under its own name — its theoretical basis rests entirely on Semax research plus the known pharmacological properties of its structural modifications.

Why People Talk About It

Cognitive enhancement and learning retention

Limited

BDNF upregulation and neuroplasticity

Limited

Enhanced blood-brain barrier penetration vs Semax

Limited

Neuroprotection and antioxidant effects

Limited

How It Works

Adamax is designed to get into the brain more effectively than its parent compound Semax. Once there, it's proposed to boost BDNF — a protein that strengthens connections between brain cells, supporting learning, memory, and cognitive function. The adamantane group acts like a molecular passport, helping the peptide cross the blood-brain barrier more efficiently.

Common Questions

Safety Information

Important Safety Notes

Common Side Effects

No formal safety data exists for Adamax specificallySemax-class peptides are generally well-tolerated (headache, nasal irritation with intranasal use)

Cautions

• Zero published safety or efficacy data specific to Adamax
• Not FDA-approved and not in clinical trials
• Quality and purity from research peptide vendors is unverified
• Extrapolating safety from Semax to a structurally modified derivative is uncertain

What We Don't Know

Everything about Adamax is unknown in a formal sense. No human or animal studies have been published. The compound's safety profile is entirely extrapolated from Semax research and general adamantane pharmacology. Whether the adamantane modification introduces new risks is unstudied.

Published Research

3 studies

Neuroprotective effects of Semax in conditions of brain ischemia.

ReviewPMID: 25371769

Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia.

PreclinicalPMID: 23585038

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

PreclinicalPMID: 17692456

Mechanism of Action

Adamax is a synthetic derivative of the ACTH(4-10) analog Semax, with N-terminal acetylation (protecting against aminopeptidase degradation) and C-terminal adamantane conjugation (a lipophilic cage hydrocarbon that enhances membrane permeability and blood-brain barrier penetration). The proposed mechanism mirrors Semax: upregulation of BDNF expression and TrkB receptor sensitivity in hippocampal neurons, modulation of monoamine neurotransmitters (dopamine, norepinephrine, serotonin), and neuroprotective effects via antioxidant and anti-inflammatory pathways. The adamantane moiety is pharmacologically significant — adamantane derivatives include established CNS drugs amantadine (dopaminergic) and memantine (NMDA antagonist), suggesting the modification may contribute additional neuroactive properties beyond improved pharmacokinetics. However, none of these proposed mechanisms have been validated for Adamax specifically.

Evidence Snapshot

Overall Confidence15%

Human Clinical Evidence

None. No human studies exist for Adamax. The parent compound Semax has moderate clinical evidence from Russian studies for stroke recovery, cognitive enhancement, and ADHD.

Animal / Preclinical

None specific to Adamax. Semax has extensive preclinical data demonstrating BDNF upregulation, neuroprotection, and cognitive enhancement in rodent models. NA-Semax-Amidate (a related derivative) also lacks independent published data.

Mechanistic Rationale

Theoretical. The rationale combines validated Semax pharmacology with known properties of adamantane modifications (enhanced lipophilicity, BBB penetration, metabolic stability). Sound in principle but unvalidated for this specific compound.

Forms & Administration

Adamax is available as a research compound, typically as a nasal spray or lyophilized powder. Intranasal administration is the most common route for nootropic peptides in this class. It is not FDA-approved and not available through legitimate medical channels.

Use Cases & Evidence Levels

Cognitive enhancement and learning retention

Limited15%

BDNF upregulation and neuroplasticity

Limited15%

Enhanced blood-brain barrier penetration vs Semax

Limited15%

Neuroprotection and antioxidant effects

Limited15%

Safety Profile

Safety Information

Common Side Effects

No formal safety data exists for Adamax specificallySemax-class peptides are generally well-tolerated (headache, nasal irritation with intranasal use)

Cautions

• Zero published safety or efficacy data specific to Adamax
• Not FDA-approved and not in clinical trials
• Quality and purity from research peptide vendors is unverified
• Extrapolating safety from Semax to a structurally modified derivative is uncertain

What We Don't Know

Published Research

3 studies

Neuroprotective effects of Semax in conditions of brain ischemia.

ReviewPMID: 25371769

Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia.

PreclinicalPMID: 23585038

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

PreclinicalPMID: 17692456

Related Peptides

Semax

EmergingBeginner

A synthetic peptide analog of ACTH(4-10) developed in Russia, studied for cognitive enhancement and neuroprotection.

NA-Semax-Amidate

Limited

A chemically modified version of Semax designed for improved stability. No published clinical or preclinical data exists for this specific compound.

Selank

EmergingBeginner

A synthetic peptide analog of tuftsin with anxiolytic and nootropic properties, developed in Russia.

N-Acetyl Selank Amidate

EmergingBeginner

An enhanced version of Selank with improved stability, studied for anxiety reduction and cognitive enhancement.

Dihexa

Preliminary

A potent angiotensin IV analog studied for cognitive enhancement and potential treatment of neurodegenerative conditions.

P21

Preliminary

A CNTF-derived peptide that promotes neurogenesis and has shown promise in Alzheimer's disease research.

Quick Facts

Class: Nootropic Peptide
Evidence: Limited
Safety: Limited Data
Updated: Apr 2026
Citations: 3PubMed

Also known as

Acetyl-Semax-AdamantaneN-Acetyl Semax Adamantane

Evidence Score

Overall Confidence15%

Clinical Trials

View Clinical Trials

Links to ClinicalTrials.gov for reference. Listing does not imply endorsement.